Sharing Life Sciences Innovations
The million-dollar question: How much do you charge for a lifesaving drug?
The newest generation of ground-breaking gene therapy drugs, Zolgensma and Zynteglo, come with eye-catching price tags of more than a million dollars per treatment. Is the pharma industry reckless…
Galapagos-Gilead billion-dollar deal: beyond the numbers
Last month, Galapagos sealed a 5-billion-dollar deal with Gilead. Now that the dust has started to settle, we’re taking a closer look at the agreement. Why is this deal so unique in the biotech wo…
Why events are important for creating connections in the life sciences
Collaboration is vital for science. Without cross-pollination of ideas and talent, progress would be excruciatingly slow in both industry and academia. Networking opportunities, like the annual Kn…
How do we reduce the high cost of clinical trials?
Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. Why are clinical trials so insanely expe…
Living on the edge: the challenge of doing things differently in cell therapy
Belgian company Celyad is a trailblazer in oncology: its T cell therapies based on NK receptors are cutting edge even for CAR-T. At the Science for health event in September the visionary Christia…
Solving food waste one StixFresh sticker at a time
Food waste is a major global issue exacerbated by premature fruit spoilage. A US company, StixFresh, is working together with VIB-KU Leuven Prof Patrick Van Dijck to develop a solution to the prob…
Gilead and Galapagos enter into transformative research and development collaboration
Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment Gilead Gains Access to Galapagos’ Differentiated Drug Discovery Platform and Current and Future Pipeline O…
WELBIO joins ranks with celebrities after a new bacterium is named after the institute
WELBIO has received a truly unique form of acknowledgement: a newly discovered bacterium has been named after the research institute. The human gut microbe was discovered during a project led by P…
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
Ghent, Belgium, and Dresden, Germany - 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH today announce a drug discovery collaboration on an undisclosed G-pro…
Betting big on blood screens for early cancer detection
The American Society of Clinical Oncology (ASCO) just held their annual gathering in Chicago. The event coincided with some interesting new developments in the field of early cancer detection, as …
Stellar year for Belgian biotech
Belgium has once again strengthened its position as Europe's biotech leader. Today, Belgian biotech companies comprise 23 percent of the total market value of all public European biotech companies…
Join our mailing list and receive the monthly BioVox newsletter for free!
Upcoming events
Dr. Paul Janssen Award for Biomedical Research 2019
JANSSEN BELGIUM
Turnhoutseweg 30
2340 Beerse
Belgium
Fri 27 Sep 2019
14:00
Johnson & Johnson has named Franz-Ulrich Hartl, M.D., of the Max Planck Institute of Biochemistry and Arthur Horwich, M.D., of Yale School of Medicine and Howard Hughes Medical Institute as winner…
VFB Investor Congress "Dag van de Tips"
Gent ICC
Van Rysselberghedreef 2
9000 Gent
Sat 28 Sep 2019
08:30
VFB Investor Congress "Dag van de Tips" (Expert Tips Day) will take place on September the 28th in the beautiful Ghent ICC! Bank analysts, stock exchange houses, investment magazines and VFB …
Immunity for Health 2019
University Hasselt (Old Prison building)
Martelarenlaan 42
3500 Hasselt
Belgium
Tue 15 Oct 2019
08:30
On October 15th 2019 Flanders Vaccine is happy to host its 4th edition of “Immunity for Health”; the Flanders Vaccine annual flagship event where all experts, both from the human and animal health…
